Impact of Different Intraocular Pressure and Medication Endpoint Criteria on Success Rates in Subconjunctival Minimally Invasive Glaucoma Surgery.
Jeremy C K Tan, George Kong, Arnould Louis, Vincent Lee, Colin Clement, Jason Cheng, Gus Gazzard, Mitchell Lawlor
Summary
Using different IOP and medication criteria to define success can have a significant influence on the apparent risk of failure, particularly at the 21 mm Hg threshold and when incorporating a minimum 20% IOP reduction from baseline.
Abstract
PRCIS
Applying different combinations of intraocular pressure and medication endpoint criteria recommended by the World Glaucoma Association can have a significant influence on the risk of failure following glaucoma surgery, which hinders the comparison of outcomes.
PURPOSE
The definition of success in glaucoma surgical trials lacks standardization, leading to difficulty comparing outcomes across studies. This study evaluates how different intraocular pressure (IOP) and medication criteria affect success in a representative subconjunctival minimally invasive glaucoma surgery (MIGS) dataset.
METHODS
A literature review identified the range of criteria used to define surgical success in studies of Xen gel stent, which were summarized into 4 definitions: (A) final IOP within upper and lower thresholds only, (B) criteria A plus ≥20% decrease in IOP verssus baseline, (C) ≥20% IOP decrease plus no increase in medications versus baseline, (D) all 3 criteria combined. These definitions were then applied to a cohort of 308 eyes that underwent Xen surgery to compare the apparent risks of failure.
RESULTS
Success rates at 12 months across studies reviewed ranged from 18.5% to 33.4% for complete and 22.4% to 64.6% for qualified success. In our cohort, the hazard ratios of failure ranged from 0.27 to 5.87 (95%
CI
0.21-7.63, P <0.001) across the 4 definitions. The greatest degree of difference in apparent failure rates was observed at the upper IOP threshold of 21 mm Hg, and when evaluating qualified success.
CONCLUSION
Using different IOP and medication criteria to define success can have a significant influence on the apparent risk of failure, particularly at the 21 mm Hg threshold and when incorporating a minimum 20% IOP reduction from baseline. Reporting success using guidelines-recommended criteria-and at multiple upper IOP thresholds may enable better comparison of outcomes between studies.
Keywords
More by Jeremy C K Tan
View full profile →Clinical Registries in Ophthalmology.
Frontloading SITA-Faster Can Increase Frequency and Reliability of Visual Field Testing at Minimal Time Cost.
Evaluation of the Consistency of Glaucomatous Visual Field Defects Using a Clustered SITA-Faster Protocol.
Top Research in Glaucoma Surgery
Browse all →Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.